Versatile coordination behaviour of Ph2AsCH2AsPh2 with Ru(II)

Treatment of ‘RuCl₃ · 3H₂O’ with Ph₂AsCH₂AsPh₂ (dpam) in hot EtOH gives either trans-[RuCl₂(dpam-As,As′)(dpam-As)₂] (1), or cis-[RuCl₂(dpam-As,As′)₂] (2), depending on the mole ratio. On exposure to light, solutions of 2 isomerise to trans-[RuCl₂(dpam-As,As′)₂] (3). Treatment of [RuCl₂(PPh₃)₃] with two equivalents of dpam in CH₂Cl₂ gave a mixture of two products, from which trans-[RuCl₂(PPh₃) (dpam-As,As′)(dpam-As)] (4) was isolated by recrystallisation. The crystal structures of 1-4 are reported. Complexes 1-3 in CH₂Cl₂ undergo electrochemical oxidation to Ru(III), and the Ru(III) form of 2 undergoes isomerisation on the voltammetric timescale to the Ru(III) form of 3.     

Unexpected formation and structure elucidation of mer-[RuCl3(TMSO)(bpy)] derived from [H(TMSO)][trans-RuCl4(TMSO)2] under mild condition

Treatment of [H(TMSO)][trans-RuCl₄(TMSO)₂] (1) with 2,2′-bipyridine (bpy) in ethanol at room temperature resulted an unknown mer-[RuCl₃(TMSO)(bpy)] (3) and a known cis-[RuCl₂(TMSO)₄] (4) (TMSO =  tetramethylene sulfoxide) complexes. The 3 was obtained by the substitution with bpy in mer-[RuCl₃(TMSO)₃] (2), whereas 4 was obtained by one-electron reduction of 2, suggesting that 2 is a precursor for both 3 and 4. The structure of 3 was determined by single crystal X-ray diffraction. The reaction is a new synthetic procedure for 3 and/or 3 and 4 in mild reaction conditions from the anionic complex 1. It involves simultaneous substitution and redox reaction. This is the first known example of precisely characterized Ru(III)-chloride-TMSO-bpy-complex derived from anionic [H(TMSO)][trans-RuCl₄(TMSO)₂] at room temperature.     

Synthesis, characterization and kinetic studies of the cis-[RuCl2(cyclen)] complex

We report here the synthesis, characterization and kinetic studies of cis-[RuCl₂(cyclen)]⁺ in aqueous solution, where cyclen is the macrocyclic ligand 1,4,7,10-tetraazacyclododecane. The complex releases one Cl⁻ producing cis-[RuCl(OH)(cyclen)]⁺ in aqueous solution at pH 4.60. The product of this reaction was characterized by Ultraviolet-Visible (UV-Vis) spectrum in comparison to the synthesized cis-[RuCl(OH)(cyclen)](BF₄)·2H₂O. The electrochemical data showed that E_pc of the Ru(III/II) peak increases as the macrocycle ring size decreases and also when the trans conformation is changed to cis. The chloride affinity of Ru(III) depends on the macrocycle ring size since cis-[RuCl₂(cyclam)]⁺ (cyclam=1,4,8,11-tetraazacyclotetradecane) does not release chloride for at least 12 h. The overall effect between cyclam and cyclen reflects the fact that the electron involved in the reduction enters a nonbonding π-d orbital and its energy is affected by the macrocyclic ligand.     

In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A

A series of novel octahedral ruthenium(III) complexes involving 6-benzylaminopurine (L) derivatives as N-donor ligands has been prepared by the reaction of [(DMSO)₂H][trans-RuCl₄(DMSO)₂] with the corresponding L derivative. The complexes 1-12 have the general compositions trans-[RuCl₄(DMSO)(n-Cl-LH)] ⋅ xSol (1-3), trans-[RuCl₄(DMSO)(n-Br-LH)] · xSol (4-6), trans-[RuCl₄(DMSO)(n-OMe-LH)] · xSol (7-9) and trans-[RuCl₄(DMSO)(n-OH-LH)] · xSol (10-12); n = 2, 3, and 4, x = 0-1.5; and Sol = H₂O, DMSO, EtOH and/or (Me)₂CO. The complexes have been thoroughly characterized by elemental analysis, UV-visible, FTIR, Raman, and EPR spectroscopy, ES + (positive ionization electrospray) mass spectrometry, thermal analysis, cyclic voltammetry, magnetic and conductivity measurements. The X-ray molecular structure of trans-[RuCl₄(DMSO)(3-Br-LH)] ⋅ (Me)₂CO (5) revealed the distorted octahedral coordination in the vicinity of the central atom, and also confirmed that the 3-Br-L ligand is present as the N3-protonated N7-H tautomer and is coordinated to Ru(III) through the N9 atom of the purine moiety. The tested complexes have been found to be in vitro non-cytotoxic against K562, G361, HOS and MCF7 human cancer cell lines with IC₅₀ > 100 μM in contrast to the moderate results regarding the antiradical activity with IC₅₀ ≈ 10^− 3 M. On the contrary, in vivo antitumor activity screening showed that the prepared Ru(III) complexes possess higher pro-apoptotic activity than NAMI-A. The reduction of Ru(III) to Ru(II) and Ru(II)-species formation in tumor tissues was confirmed by means of a simple method of detection and visualization of intracellular Ru(II) by fluorescence microscopy. The originality of this method is based on the preparation of a Ru(II)-bipyridine complex in situ.     

Formation and molecular structure of novel Ru(III) dimers of a symmetric antitumor drug analogue

The symmetrical anionic and neutral dimers [H(TMSO)₂]₂trans-[{RuCl₄(TMSO)}₂](μ-pyz) (1), and mer-[{RuCl₃(TMSO)₂}₂](μ-pyz) (2) were isolated by the reaction of [H(TMSO)] trans-[RuCl₄(TMSO)₂] and mer-[RuCl₃(TMSO)₃] with heterocyclic nitrogen donor ligand pyrazine (pyz) at room temperature. These complexes can be regarded as unprecedented examples in the general Creutz-Taube family of ruthenium dimers. Each ruthenium center in 1 and 2 has a coordination environment akin to that of known anionic and neutral monomeric Ru(III) complexes. Crystals of 1 · acetone are orange, needle like, space group , a=10.419(3) Å, b=10.539(3) Å, c=12.595(5) Å, α=69.837(16)°, β=69.968(15)°, γ=74.330(15)° and crystals of 2 · 4TMSO are orange prisms, trigonal, space group , a=33.971(5) Å, b=33.971(5) Å, c=12.210(2) Å, α=90°, β=90° and γ=120°.     

The unexpected reactions of [RuCl3(2mqn)NO] (H2mqn=2-methyl-8-quinolinol) with 2-chloro-8-quinolinol (H2cqn) and of [RuCl(2cqn)(2mqn)NO] on photoirradiation

The reaction of [RuCl₃(2mqn)NO]⁻ (H2mqn=2-methyl-8-quinolinol) with 2-chloro-8-quinolinol (H2cqn) afforded cis-1 [RuCl(2cqn)(2mqn)NO] (the oxygen of 2cqn is trans to the NO) (complex 1), cis-1 [RuCl(2cqn)(2mqn)NO] (the oxygen of 2mqn is trans to the NO) (complex 2) and a 1:1 mixture of cis-2 [RuCl(2cqn)(2mqn)NO] (the oxygen of 2mqn is trans to the NO) and cis-2 [RuCl(2cqn)(2mqn)NO] (the oxygen of 2cqn is trans to the NO) (complex 3). The reaction was compared with that of [RuCl₃(2mqn)NO]⁻ with 8-quinolinol (Hqn) or 5-chloro-8-quinolinol (H5cqn). Photoirradiation reaction of complex 1 at room temperature in deaerated CH₂Cl₂ in the presence of NO gave trans-[RuCl(2cqn)(2mqn)NO] (the Cl is trans to the NO) and complex 2 with recovery of complex 1. The reaction was contrasted with that of cis-1 [RuCl(qn)(2mqn)NO] or cis-1 [RuCl(5cqn)(2mqn)NO]. The crystal structure of complex 1 was determined by X-ray diffraction. The reactions were examined under consideration of atomic charge of the phenolato oxygen in 8-quinolinol and its derivatives calculated at the restricted Hartree-Fock/6-311G** level.     

Synthesis of ruthenium(II) monosubstituted squarates: 1. Procedural considerations

Attempted syntheses of ruthenium(II) monosubstituted squarate complexes in acetonitrile using cis-[RuCl₂(dmso)₄] and anisole-, methoxy-, methyl- and diphenylamino-squarate ligands, respectively, resulted in the formation in each case of the monomer cis, fac-Ru(CH₃CN)Cl₂(dmso)₃ (1) with the ruthenium atom in a distorted octahedral environment. A second crop of crystals harvested from the reaction with the methoxysquarate ligand was identified as the oxalato-bridged dimer [{cis-(CH₃CN)(Cl)(dmso)₂Ru}₂(μ-C₂O₄)] (2). When cis-[RuCl₂(dmso)₄] and methylsquarate were reacted in aqueous solution instead of acetonitrile, the dimer [{fac-(Cl)(dmso)₃Ru}₂(μ-C₂O₄)] (3) was produced. The dimers 2 and 3 are formed from oxidation/ring opening of the methoxy- and methyl-squarate ligands, respectively. Use of the salts of these ligands instead of their non-ionised forms under different reaction conditions, afforded [Na] fac-[RuCl₃(dmso)₃] (4) and [(C₄H₉)₄N]₂[(C₄O₄)(C₄H₂O₄)₂] (7), respectively, which were shown to be products of competing reactions. The information acquired from these failed attempts has provided the basis for the development of a strategy to overcome these problems and lead to a successful synthetic route to ruthenium(II) monosubstituted squarates.     

The first report on specific binding mode of diethylmalonate acting as a bridging ligand between ruthenium (II) ions stabilized by intramolecular hydrogen bonds

Typically 2,2-diethylmalonate (dem) acts as a chelating ligand and binds to the metal in a η² (dem-O, O′) mode. However, when cis,fac-[RuCl₂(TMSO-S)₄] is treated with K₂(dem), it prefers to bind in an unusual bridging mode (μ-dem-O, O′) with the ruthenium (II) cation containing coordinated water, forming a strong hydrogen bond with the non-coordinated oxygen atoms of the 2,2-diethylmalonate ligand. The reaction products of cis,fac-[RuCl₂(TMSO-S)₄] (1) and cis,fac-[RuCl₂(DMSO-S)₃(DMSO-O)] (2) with dem are the dinuclear species with two bridging dem units, fac-[Ru(TMSO-S)₃(H₂O)(μ²-dem-O, O′)]₂ (3) and fac-[Ru(DMSO-S)₃(H₂O)(μ²-dem-O, O′)]₂ (4), respectively. The complex 3 was characterized by X-ray crystallography in which water ligands occupy anti positions with respect to each other. The NMR and X-ray study support each other with respect to dinuclear structure of 3 and 4, indicating that the dinuclear structure observed in the solid state is preserved in solution as well. The mononuclear anionic complex with chelating dem unit, K{fac-[RuCl(η²-dem-O, O′)(TMSO-S)₃} (5), was also isolated from the reaction of 1 and K₂(dem) demonstrating that 5 is an intermediate in the formation of 3.     

Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis,characterisation and in vitro pharmacological evaluation

Reaction of 3-pyridinehydroxamic acid and 4-pyridinehydroxamic acid (3-pyha and 4-pyha) with either [NBu₄][RuCl₄(dmso-S)₂] or [(dmso)₂H][RuCl₄(dmso-S)₂] (dmso is dimethyl sulfoxide) in acetone afforded three new ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes: [NBu₄][trans-RuCl₄(dmso-S)(4-pyha)]·CH₃COCH₃ (1), [3-pyhaH][trans-RuCl₄(dmso-S)(3-pyha)] (2) and [4-pyhaH][trans-RuCl₄(dmso-S)(4-pyha)] (3). The solid-state structure of [NBu₄][trans-RuCl₄(dmso-S)(4-pyha)]·CH₃COCH₃ (1) was determined by X-ray crystallography. 2 and 3 were pharmacologically evaluated for their in vitro cytotoxicity, their ability to inhibit cell invasion and their gelatinase activity. 2 and 3 were devoid of cytotoxicity against the cell lines tested. 2 inhibited invasion of the highly invasive MDA-MB-231 cells to a much greater extent than 3. Contrary to expectations, neither 2 nor 3 had any inhibitory effect on matrix metalloproteinase (MMP) production and/or activity and in fact 3 was found to enhance the production and/or activity of both MMP-2 and MMP-9.     

Oligophosphine ligands. XIII. Halo and hydro complexes of ruthenium(II) containing the novel tripod tetrakis(tertiary) phosphine P(CH2CH2CH2PMe2)3

The reaction of the ruthenium complexes RuCl₂(PPh₃)₃, RuCl₂(PPh₃)₄, RuCl₂(PMe₃)₄, RuCl₂(Me₂SO)₄, or RuBr₂(PPh₃)₃ with the tripod tetrakis(tertiary) phosphine P(CH₂CH₂CH₂PMe₂)₃ gave the compounds cis-RuCl₂ [P(CH₂CH₂CH₂PMe₂)₃] (1) and cis-RuBr₂[P(CH₂CH₂CH₂PMe₂)₃] (2). The coordination geometry of 1 and 2 was derived from the ABX₂ type ³¹P NMR patterns of the complexes, as well as from an X-ray structure determination for the chloride 1. Crystals of 1 were found to be monoclinic, space group P2₁/n (Z = 4), with a = 942.0(3), b = 1446.2(4), c = 1680(1) pm, and β = 104.99(4)°. Anisotropic refinement of the structure converged at R = 0.040 and R_w = 0.034 (3318 data). Selected bond lengths are (in pm): RuP(CH₂−)Me₂ (trans-atom P), 235.8(1) and 239.3(1); RuP(CH₂−)Me₂ (trans-atom Cl), 227.9(1); RuP(CH₂−)₃, 225.3(1); RuCl (trans-group P(CH₂−)₃), 252.1(1); and RuCl (trans-group P(CH₂)Me₂), 250.5(1). Reaction of 1 with LiAlH₄ yielded the hydro derivatives cis-Ru(H)Cl[P(CH₂CH₂CH₂PMe₂)₃] (3) and cis-RuH₂[P(CH₂CH₂CH₂PMe₂)₃] (4), which were characterized by IR and ¹H and ³¹p NMR spectroscopy.     

Chemo-selective hydrolysis of the iminic moiety in salicylaldehyde semicarbazone promoted by ruthenium

ortho-Hydroxybenzaldehyde semicarbazone (salicylaldehyde semicarbazone) undergoes chemo-selective hydrolysis of the iminic carbon nitrogen double bond through its reaction with [RuCl₂(dmso)₄] in ethanol in the presence of water, yielding free salicylaldehyde and semicarbazide that remains coordinated to the ruthenium ion as a bidentate N,O-donor to afford [RuCl₂(dmso)₂(semicarbazide)] · 2H₂O complex. The ruthenium-semicarbazide complex has been characterized by ¹H NMR and FTIR spectroscopies and X-ray diffraction methods. Related semicarbazones, derived from p-hydroxybenzaldehyde and benzaldehyde, were not hydrolyzed under the same conditions, suggesting a significant role of the structural o-hydroxy motive in the reaction. Theoretical studies were performed in order to gain further insight on the mechanism of reaction. Results support the hypothesis that the ortho-hydroxy moiety, in the keto tautomeric form, participates in the chemo-selective hydrolysis promoted by [RuCl₂(dmso)₄].     

Mutagenic activity of platinum and ruthenium complexes

cis-Dichlorodiammineplatinum(II) [cis-PtCl₂(NH₃)₂] and dichlorotetrakis (dimethylsulfoxide) ruthenium(II) [RuCl₂(DMSO)₄] have been tested as mutagens for strains of Salmonella typhimurium carrying the hisG46 missense mutation. Their activity, which has been compared with the activity of mitomycin C, depends on the presence in the test bacteria of the pKM101 plasmid and is affected in various ways by the function of the excision repair system. More precisely, mitomycin C is mutagenic only for strains with an intact uvr system. cisPtCl₂(NH₃)₂ and RuCl₂(DMSO)₄ are mutagens both for uvrB and uvr⁺ strains, but cis-PtCl₂(NH₃)₂ is more active on the latter, while the converse is true for RuCl₂(DMSO)₄. It seems, therefore, that each drug interacts with DNA by a different mechanism.     

Reactivity of trans-[PtCl2(NCMe)2] with cycloaliphatic amines: An ESI and NMR study. X-ray structure of

The reactivity of the cyclic primary aliphatic amines cyclopropyl-, cyclopentyl- and cyclohexylamine with cis- and trans-[PtCl₂(NCMe)₂], under the same experimental conditions, is compared. Whereas cis-[PtCl₂(NCMe)₂] yields the neutral diamidine compounds, the reactions with trans-[PtCl₂(NCMe)₂] take place either with addition or substitution processes yielding the neutral diamidine complexes trans-[PtCl₂(Amidine)₂], the monocationic trans-[PtCl(Amine)(Amidine)₂]Cl and the dicationic trans-[Pt(Amine)₂(Amidine)₂]Cl₂ salts. An NMR and ESI study indicate that the main species formed is the monocationic trans-[PtCl(Amine)(Amidine)₂]Cl complex.The X-ray structure of is reported and its supramolecular arrangement is described.     

trans-[Ru(N-N)2Cl2] species, where N-N is bis(3,5-dimethylpyrazol-1-yl)methane

Using bis(3,5-dimethylpyrazol-1-yl)methane as an N-N donor ligand, a trans-[Ru^III(N-N)₂Cl₂]⁺ core has been isolated from the direct reaction of the ligand with RuCl₃ · xH₂O and characterized structurally for the first time. The core displays a rhombic EPR spectrum and a quasireversible Ru(II/III) couple with an E_1/2 of −0.34 V versus NHE.     

A new route to N(1)-5R-tetrazole complexes via azidation to nitriles coordinated to Pt(II) and Pt(IV)

New tetrazolate complexes trans-[PtCl₂(RCN₄)₂]²⁻, trans-[PtCl₄(RCN₄)₂]²⁻ with Ph₃PCH₂Ph⁺ and (CH₃)₂NH₂⁺ counterions have been obtained by azidation of nitriles coordinated to Pt(II) and Pt(IV) {trans-[PtCl₂(RCN)₂] and trans-[PtCl₄(RCN)₂] (R = Et, Ph)} and characterized. The composition and the molecular structure of the complexes obtained were established by the СHN elemental analyses, ¹Н and ¹³С NMR spectroscopy, IR spectroscopy, mass spectrometry, and X-ray diffraction. The coordination of nitriles to Pt(II) and Pt(IV) is shown significantly activate the azidation: the reaction proceeds with a higher rate and at relatively low temperature compared with the classical 1,3-dipolar addition of azides to nitriles.     

Study of Pt(II)-cyclic amines complexes of the types cis- and trans-Pt(amine)2I2 and cis- and trans-Pt(amine)2(NO3)2 and their aqueous products by

Complexes of the types cis- and trans-Pt(amine)₂I₂ containing cyclic amines were synthesized and studied mainly by IR and multinuclear NMR spectroscopies. The compounds were converted to cis- and trans-Pt(amine)₂(NO₃)₂, which were also investigated. The hydrolysis and the aquation reactions of the latter compounds were then studied in D₂O in different conditions of pH. In acidic medium, the aqueous product is [Pt(amine)₂(D₂O)₂]²⁺ and for a few amines, [Pt(amine)₂(D₂O)(NO₃)]⁺ was detected. In basic pH, the main product is Pt(amine)₂(OD)₂ and Pt(amine)₂(OD)(NO₃) was detected for several compounds. In neutral pH, the cis isomers form between two and four species in fresh solutions. The most shielded species in ¹⁹⁵Pt NMR is the monoaqua-monohydroxo complex cis-[Pt(amine)₂(D₂O)(OD)]⁺ and the less shielded compound is the dihydroxo-bridged dimer [Pt(amine)₂(μ-OD)₂Pt(amine)₂]²⁺, which were observed for all the compounds. For a few amines, the monohydroxo-bridged dimer [Pt(D₂O)(amine)₂(μ-OD)Pt(OD)(amine)₂]²⁺ was detected and for cyclohexylamine, a fourth signal was assigned to a cyclic hydroxo-bridged trimer [(Pt(amine)₂(μ-OD))₃]³⁺. ¹⁹⁵Pt NMR spectroscopy has shown that the concentration of the monomer decreases with time, while the concentration of the dimers increases. Only one product was observed for the trans isomers in neutral pH. The signal was assigned to the monoaqua-monohydroxo species trans-[Pt(amine)₂(D₂O)(OD)]⁺. The ¹³C and ¹H NMR spectra of most of the complexes were measured. All the coupling constants ^2,3J(¹⁹⁵Pt-¹H) and ^2,3J(¹⁹⁵Pt-¹³C) are larger in the cis compounds than in the trans isomers.     

Macropolyhedral boron-containing cluster chemistry : Products of the reaction between [{Ru(η-MeC6H4Pr)Cl2}2] and syn-[B18H22]. A syn → anti 18-vertex configurational change

Reaction of [{RuCl₂(η⁶-MeC₆H₄^isoPr)}₂] with syn-[B₁₈H₂₂] and non-nucleophilic base results in [8-(η⁶-MeC₆H₄^isoPr)-8-RuB₁₇H₂₁], of 18-vertex anti 10-vertex-nido-10-vertex-nido configuration, as the predominant product. The syn → anti configurational change arises from a trans-cluster pseudo-vertex-substitution of a {BH} vertex by the {Ru₂(η⁶-MeC₆H₄^isoPr)} centre.     

Synthesis,structural characterization and cell death-inducing effect of novel palladium(II) and platinum(II) saccharinate complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine on cancer cells in vitro

Four palladium(II) and platinum(II) saccharinate (sac) complexes with 2-(hydroxymethyl)pyridine (2-hmpy) and 2-(2-hydroxyethyl)pyridine (2-hepy), namely trans-[Pd(2-hmpy)₂(sac)₂]·H₂O (1), trans-[Pt(2-hmpy)₂(sac)₂]·3H₂O (2), trans-[Pd(2-hepy)₂(sac)₂] (3) and trans-[Pt(2-hepy)₂(sac)₂] (4), have been synthesized and characterized by elemental analysis, UV–vis, IR and NMR. Single crystal X-ray analysis reveals that the metal(II) ions in each complex are coordinated by two sac and two 2-hmpy or 2-hepy ligands with a trans arrangement. Anticancer effects of 1–4 were tested against four different cancer cell lines (A549 and PC3 for lung cancer, C6 for glioblastoma, and Hep3B for liver cancer). Cytotoxicity was first screened by the MTT assay and the results were further confirmed by the ATP assay. The mode of cell death was determined by both histological and biochemical methods. Among the metal complexes, complex 2 resulted in relatively stronger anti-growth effect in a dose-dependent manner (3.13–200 μM), compared to the others, by inducing apoptosis.     

New arene ruthenium complexes with planar chirality

1,2,4-Trimethyl-cyclohexadiene reacts with RuCl₃ · nH₂O in refluxing ethanol to afford quantitatively [RuCl₂(1,2,4-C₆H₃Me₃)]₂ (1), the coordination of 1,2,4-trimethylbenzene to the ruthenium atom introducing planar chirality at the η⁶-arene ligand. The dinuclear complex 1 reacts with two equivalents of triphenylphosphine (PPh₃) to give quantitatively, as a racemic mixture of enantiomers, [RuCl₂(1,2,4-C₆H₃Me₃)(PPh₃)] (2), the structure of which has been determined by a single-crystal X-ray structure analysis of (rac)-2. Similarly, 1 reacts with two equivalents of the enantiopure phosphine (1S,2S,5R)-(+)-neomenthyldiphenylphosphine (nmdpp) to afford in good yield [RuCl₂(1,2,4-C₆H₃Me₃)(nmdpp)] (3) as a mixture of diastereoisomers, from which the isomer 3a was isolated by crystallisation. A single-crystal X-ray structure analysis of 3a allowed the determination of the absolute configuration at the planar chiral η⁶-arene moiety. Finally, complex 1 reacts with one equivalent of the diphosphine ligand 1,1^′-bis(diphenylphosphino)ferrocene (dppfc) to give the heteronuclear complex [RuCl₂(1,2,4-C₆H₃Me₃) (dppfc)RuCl₂(1,2,4-C₆H₃Me₃)] (4). All complexes were fully characterised by elemental analysis, mass spectrometry, NMR and IR spectroscopies.     

Novel p-tolylimido rhenium(V) complexes incorporating quinoline-2-carboxylate ion - Synthesis, X-ray studies, spectroscopic characterization and DFT calculations

Novel p-tolylimido rhenium(V) complexes trans-[Re(p-NC₆H₄CH₃)X₂(quin-2-COO)(PPh₃)] and cis-[Re(p-NC₆H₄CH₃)X₂(quin-2-COO)(PPh₃)]·MeCN have been obtained in the reactions of [Re(p-NC₆H₄CH₃)X₃(PPh₃)₂] (X = Cl, Br) with quinoline-2-carboxylic acid. The compounds were identified by elemental analysis IR, UV-Vis spectroscopy and X-ray crystallography. The electronic structures of trans- and cis-halide isomers of [Re(p-NC₆H₄CH₃)Cl₂(quin-2-COO)(PPh₃)] have been calculated with the density functional theory (DFT) method. Additional information about binding in the compounds [Re(p-NC₆H₄CH₃)Cl₂(quin-2-COO)(PPh₃)] with cis- and trans-halide arrangement has been obtained by NBO analysis. The electronic spectra of trans and cis isomers of [Re(p-NC₆H₄CH₃)Cl₂(quin-2-COO)(PPh₃)] were investigated at the TDDFT level employing B3LYP functional in combination with LANL2DZ.